Health
Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes – News-Medical.Net
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been mounting, with studies showing better blood glucose control, cardiovascular benefits, weight loss and more for patients with diabetes taking SGLT2 inhibitors.
Now, two large clinical trials, conducted by investigators at…
-
Noosa News5 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
Noosa News14 hours agoCity of Moreton Bay throws homeless people’s tents into garbage trucks
-
General11 hours agoUN special envoy Julie Bishop makes first trip to Myanmar after earthquake
-
General9 hours agoNZ PM wants united trade bloc-EU response to tariffs